Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 113

1.

Circadian hypo- and hyper-amplitude-tension (CHAT) associated with putative pheochromocytoma and 12-hourly phenoxybenzamine treatment.

Sabath LD, Cornélissen G, Halberg F, Stoynev A, Ikonomov O, Otsuka K.

Biomed Pharmacother. 2004 Oct;58 Suppl 1:S99-106.

PMID:
15754846
2.

Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections.

Pankey GA, Sabath LD.

Clin Infect Dis. 2004 Mar 15;38(6):864-70. Epub 2004 Mar 1. Review.

PMID:
14999632
3.

In vitro activity of ceftriaxone and other cephalosporins against 602 clinical isolates of staphylococci from geographically diverse medical centers.

Pfaller MA, Barry AL, Sabath LD, Kreiswirth BN, Murray PR, Fuchs PC, McLaughlin JC.

Eur J Epidemiol. 1993 Nov;9(6):658-62.

PMID:
8150070
4.

Antibiotic resistance. Epidemiology and therapeutics.

Neu HC, Duma RJ, Jones RN, McGowan JE Jr, O'Brien TF, Sabath LD, Sanders CC, Schaffner W, Tally FP, Tenover FC, et al.

Diagn Microbiol Infect Dis. 1992 Feb;15(2 Suppl):53S-60S. No abstract available.

PMID:
1737445
5.

Therapeutic and epidemiologic recommendations to reduce the spread of type-I beta-lactamase resistance.

Neu HC, Duma RJ, Jones RN, McGowan JE Jr, O'Brien TF, Sabath LD, Sanders CC, Schaffner W, Tenover FC, Young LS.

Diagn Microbiol Infect Dis. 1992 Feb;15(2 Suppl):49S-52S. Review.

PMID:
1737444
6.
7.

Some historical aspects of bacterial resistance.

Sabath LD.

Bull N Y Acad Med. 1987 Apr;63(3):330-6. No abstract available.

8.

Penetration of aztreonam into human cerebrospinal fluid in the presence of meningeal inflammation.

Greenman RL, Arcey SM, Dickinson GM, Mokhbat JE, Sabath LD, Platt TB, Friedhoff LT.

J Antimicrob Chemother. 1985 May;15(5):637-40.

PMID:
4040132
10.

The outlook for prevention and treatment of infections due to Pseudomonas aeruginosa.

Young LS, Wenzel RP, Sabath LD, Pollack M, Pennington JE, Platt R.

Rev Infect Dis. 1984 Sep-Oct;6 Suppl 3:S769-74.

PMID:
6443776
11.
12.

Peritonitis due to Mycoplasma hominis in a renal transplant recipient.

Mokhbat JE, Peterson PK, Sabath LD, Robertson JA.

J Infect Dis. 1982 Nov;146(5):713. No abstract available.

PMID:
6752300
13.
14.

Anti-staphylococcal activity of a penem, Sch 29482.

Sabath LD, Munyan M, Mach P.

J Antimicrob Chemother. 1982 Feb;9 Suppl C:189-94. No abstract available.

PMID:
7061369
15.

Comparison of 4 and 10 days of doxycycline treatment for urinary tract infection.

Lockey JE, Williams DN, Raij L, Sabath LD.

J Urol. 1980 Nov;124(5):643-5.

PMID:
7005459
16.

Achievements and problems from the view of a physician.

Sabath LD.

Philos Trans R Soc Lond B Biol Sci. 1980 May 16;289(1036):251-6.

PMID:
6109321
17.

Urinary tract infections in the female.

Sabath LD, Charles D.

Obstet Gynecol. 1980 May;55(5 Suppl):162S-170S. Review.

PMID:
6990331
18.

Isolation of Chlamydia trachomatis from the lower respiratory tract of adults.

Tack KJ, Peterson PK, Rasp FL, O'Leary M, Hanto D, Simmons RL, Sabath LD.

Lancet. 1980 Jan 19;1(8160):116-20.

PMID:
6101457
19.

Brackbill raises.

Sabath LD, Philipson A, Charles D.

Science. 1979 Oct 26;206(4417):405. No abstract available.

PMID:
17809354
20.

Analysis of factors influencing antibiotic usage in hospitals.

Sabath LD, Notto DA.

Prog Clin Biol Res. 1979;35:65-74. No abstract available.

PMID:
538037
21.

Antibiotic sensitivity and synergism of 'penicillin-tolerant' Staphylococcus aureus.

Rozenberg-Arska M, Fabius GT, Beens-Dekkers MA, Duursma SA, Sabath LD, Verhoef J.

Chemotherapy. 1979;25(6):352-5.

PMID:
260698
22.

Endocarditis caused by coagulase-negative staphylococci.

Williams DN, Peterson PK, Verhoef J, Laverdiere M, Sabath LD.

Infection. 1979;7(1):5-9.

PMID:
253687
23.
24.

Ethics and the use of drugs during pregnancy.

Sabath LD, Philipson A, Charles D.

Science. 1978 Nov 3;202(4367):540-1. No abstract available.

PMID:
705345
25.

Staphylococcus aureus endocarditis. Combined therapy with vancomycin and rifampin.

Faville RJ Jr, Zaske DE, Kaplan EL, Crossley K, Sabath LD, Quie PG.

JAMA. 1978 Oct 27;240(18):1963-5.

PMID:
249793
26.

Atrio-ventricular shuntinfections and endocarditis due to Staphylococcus epidermidis.

Verhoef J, Peterson PK, Williams DN, Laverdiere M, Sabath LD.

Zentralbl Bakteriol Orig A. 1978 Jul;241(1):95-100.

PMID:
696069
27.

Use of a heavy inoculum in the in vitro evaluation of the anti-staphylococcal activity of 19 cephalosporins.

Laverdiere M, Welter D, Sabath LD.

Antimicrob Agents Chemother. 1978 Apr;13(4):669-75.

28.

In vitro activity of cephalosporins against methicillin-resistant, coagulase-negative staphylococci.

Laverdiere M, Peterson P, Verhoef J, Williams DN, Sabath LD.

J Infect Dis. 1978 Mar;137(3):245-50.

PMID:
632623
29.

Tetracyclines in the treatment of genitourinary tract infections.

Sabath LD.

Bull N Y Acad Med. 1978 Feb;54(2):205-15. No abstract available.

30.

Bacterial persistence in vivo: resistance or tolerance to antibiotics.

Acar JF, Sabath LD.

Scand J Infect Dis Suppl. 1978;(14):86-91. Review.

PMID:
360377
31.

Tissue penetration of antibiotics; an overview.

Sabath LD.

Scand J Infect Dis Suppl. 1978;(14):313-5.

PMID:
279984
32.

Chemical and physical factors influencing methicillin resistance of Staphylococcus aureus and Staphylococcus epidermidis.

Sabath LD.

J Antimicrob Chemother. 1977 Nov;3 Suppl C:47-51. No abstract available.

PMID:
23376
33.

Opsonic requirements for staphylococcal phagocytosis. Heterogeneity among strains.

Verhoef J, Peterson P, Kim Y, Sabath LD, Quie PG.

Immunology. 1977 Aug;33(2):191-7.

34.

Effect of protein A on staphylococcal opsonization.

Peterson PK, Verhoef J, Sabath LD, Quie PG.

Infect Immun. 1977 Mar;15(3):760-4.

35.

A new type of penicillin resistance of Staphylococcus aureus.

Sabath LD, Wheeler N, Laverdiere M, Blazevic D, Wilkinson BJ.

Lancet. 1977 Feb 26;1(8009):443-7.

PMID:
65561
36.

Cefuroxime Resistance to Staphylococcal β-Lactamases.

Laverdiere M, Wheeler N, Sabath LD.

Proc R Soc Med. 1977;70(Suppl 9):72-3. No abstract available.

37.

Historical survey of tests to determine bacterial susceptibility to antimicrobial agents.

Laverdiere M, Sabath LD.

Mt Sinai J Med. 1977 Jan-Feb;44(1):73-88. Review. No abstract available.

PMID:
321948
38.
39.
40.

Susceptibility of recently isolated bacteria to amikacin in vitro: comparisons with four other aminoglycoside antibiotics.

Finland M, Garner C, Wilcox C, Sabath LD.

J Infect Dis. 1976 Nov;134 SUPPL:S297-307.

PMID:
825588
41.
42.

Susceptibility of "enterobacteria" to penicillins, cephalosporins, lincomycins, erythromycin, and rifampin.

Finland M, Garner C, Wilcox C, Sabath LD.

J Infect Dis. 1976 Aug;134 Suppl:S75-96.

PMID:
823280
43.
44.

Susceptibility of Staphylococcus aureus and Staphylococcus epidermidis to 65 antibiotics.

Sabath LD, Garner C, Wilcox C, Finland M.

Antimicrob Agents Chemother. 1976 Jun;9(6):962-9.

45.

The assay of antimicrobial compounds.

Sabath LD.

Hum Pathol. 1976 May;7(3):287-95.

PMID:
818005
46.

Susceptibility of Neisseria gonorrhoeae to 66 antibacterial agents in vitro.

Finland M, Garner C, Wilcox C, Sabath LD.

J Am Vener Dis Assoc. 1976 Mar;2(3):33-40. No abstract available.

PMID:
815226
47.

Susceptibility of pneumococci and Haemophilus influenzae to antibacterial agents.

Finland M, Garner C, Wilcox C, Sabath LD.

Antimicrob Agents Chemother. 1976 Feb;9(2):274-87.

48.

Erythromycin and clindamycin absorption and elimination in pregnant women.

Philipson A, Sabath LD, Charles D.

Clin Pharmacol Ther. 1976 Jan;19(1):68-77.

PMID:
1245094
49.

Susceptibility of beta-hemolytic streptococci to 65 antibacterial agents.

Finland M, Garner C, Wilcox C, Sabath LD.

Antimicrob Agents Chemother. 1976 Jan;9(1):11-9.

50.

Current status of treatment of pneumonia.

Sabath LD.

South Med J. 1975 Dec;68(12):1507-11.

PMID:
792

Supplemental Content

Loading ...
Support Center